SG11201509743WA - Lentiviral vectors containing an mhc class i, mhc class ii, or beta-2 microglobulin upstream promoter sequence - Google Patents
Lentiviral vectors containing an mhc class i, mhc class ii, or beta-2 microglobulin upstream promoter sequenceInfo
- Publication number
- SG11201509743WA SG11201509743WA SG11201509743WA SG11201509743WA SG11201509743WA SG 11201509743W A SG11201509743W A SG 11201509743WA SG 11201509743W A SG11201509743W A SG 11201509743WA SG 11201509743W A SG11201509743W A SG 11201509743WA SG 11201509743W A SG11201509743W A SG 11201509743WA
- Authority
- SG
- Singapore
- Prior art keywords
- mhc class
- beta
- promoter sequence
- vectors containing
- lentiviral vectors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/30—Vector systems having a special element relevant for transcription being an enhancer not forming part of the promoter region
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13305738 | 2013-06-03 | ||
PCT/EP2014/060740 WO2014195159A1 (en) | 2013-06-03 | 2014-05-23 | Lentiviral vectors containing an mhc class i, mhc class ii, or beta-2 microglobulin upstream promoter sequence |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201509743WA true SG11201509743WA (en) | 2015-12-30 |
Family
ID=48578998
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201509743WA SG11201509743WA (en) | 2013-06-03 | 2014-05-23 | Lentiviral vectors containing an mhc class i, mhc class ii, or beta-2 microglobulin upstream promoter sequence |
Country Status (10)
Country | Link |
---|---|
US (1) | US9657311B2 (en) |
EP (1) | EP3004361A1 (en) |
JP (1) | JP2016520316A (en) |
KR (1) | KR20160011645A (en) |
CN (1) | CN105683383B (en) |
AU (1) | AU2014277092B2 (en) |
BR (1) | BR112015030211A2 (en) |
CA (1) | CA2913854A1 (en) |
SG (1) | SG11201509743WA (en) |
WO (1) | WO2014195159A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015056774A1 (en) * | 2013-10-18 | 2015-04-23 | 大鵬薬品工業株式会社 | Hla class i expressing non-human animal |
WO2016120489A2 (en) * | 2015-02-01 | 2016-08-04 | Theravectys | Lentiviral vectors for expression of mycobacterium tuberculosis antigens |
WO2017123918A1 (en) | 2016-01-15 | 2017-07-20 | American Gene Technologies International Inc. | Methods and compositons for the activation of gamma-delta t-cells |
US10137144B2 (en) | 2016-01-15 | 2018-11-27 | American Gene Technologies International Inc. | Methods and compositions for the activation of gamma-delta T-cells |
US20200080107A1 (en) * | 2018-09-07 | 2020-03-12 | Crispr Therapeutics Ag | Universal donor cells |
IT202100011576A1 (en) * | 2021-05-06 | 2022-11-06 | Univ Degli Studi Padova | NEW PROMOTER SEQUENCE FOR GENE THERAPY |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU726441B2 (en) * | 1995-08-21 | 2000-11-09 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Methods of assessing MHC class I expression and proteins capable of modulating class I expression |
US20070037165A1 (en) * | 2000-09-08 | 2007-02-15 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
JP2007068473A (en) * | 2005-09-07 | 2007-03-22 | Yokohama City Univ | Expression vector containing transcription factor-binding sequence of mhc gene |
CA2695433A1 (en) * | 2007-08-03 | 2009-02-12 | Institut Pasteur | Lentiviral gene transfer vectors and their medicinal applications |
EP2385107B1 (en) * | 2010-05-03 | 2016-08-24 | Institut Pasteur | Lentiviral vector based immunological compounds against malaria |
EP2666477A1 (en) * | 2012-05-23 | 2013-11-27 | Theravectys | Lentiviral vectors containing an MHC class I promoter |
CA2833173C (en) * | 2011-04-20 | 2023-09-05 | University Of Washington Through Its Center For Commercialization | Beta-2 microglobulin-deficient cells |
ES2683820T3 (en) * | 2011-09-26 | 2018-09-28 | Theravectys | Use of non-subtype B GAG proteins for lentiviral encapsidation |
WO2015063706A1 (en) * | 2013-10-31 | 2015-05-07 | Theravectys | Lentiviral vectors for expression of hiv-1 antigens |
-
2014
- 2014-05-23 WO PCT/EP2014/060740 patent/WO2014195159A1/en active Application Filing
- 2014-05-23 CN CN201480043991.XA patent/CN105683383B/en active Active
- 2014-05-23 EP EP14726584.7A patent/EP3004361A1/en not_active Withdrawn
- 2014-05-23 JP JP2016515755A patent/JP2016520316A/en active Pending
- 2014-05-23 BR BR112015030211A patent/BR112015030211A2/en not_active IP Right Cessation
- 2014-05-23 CA CA2913854A patent/CA2913854A1/en not_active Abandoned
- 2014-05-23 AU AU2014277092A patent/AU2014277092B2/en not_active Ceased
- 2014-05-23 SG SG11201509743WA patent/SG11201509743WA/en unknown
- 2014-05-23 KR KR1020157034528A patent/KR20160011645A/en not_active Application Discontinuation
- 2014-05-27 US US14/287,699 patent/US9657311B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
AU2014277092A1 (en) | 2015-12-10 |
CN105683383A (en) | 2016-06-15 |
JP2016520316A (en) | 2016-07-14 |
US20140356946A1 (en) | 2014-12-04 |
EP3004361A1 (en) | 2016-04-13 |
AU2014277092B2 (en) | 2019-04-04 |
US9657311B2 (en) | 2017-05-23 |
WO2014195159A1 (en) | 2014-12-11 |
CN105683383B (en) | 2020-08-21 |
KR20160011645A (en) | 2016-02-01 |
CA2913854A1 (en) | 2014-12-11 |
BR112015030211A2 (en) | 2017-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1247815A1 (en) | Claudin-18.2-specific immunoreceptors and t cell epitopes | |
DK3083694T3 (en) | CANINIZED, MURINE ANTI-CANIN-PD-1 ANTIBODIES | |
EP3200086A4 (en) | Mobile device, hmd and system | |
PL3145949T3 (en) | Lentiviral vectors | |
DK2723615T3 (en) | ACCIDENT FIGHTING SYSTEM AND VEHICLE INCLUDING THE ACCIDENT FIGHTING SYSTEM | |
ZA201506141B (en) | Flexible conveyance system | |
IL245907A0 (en) | Stable episomes based on non-integrative lentiviral vectors | |
SG11201509743WA (en) | Lentiviral vectors containing an mhc class i, mhc class ii, or beta-2 microglobulin upstream promoter sequence | |
EP3036702A4 (en) | Sourcing abound candidates apparatuses, methods and systems | |
HK1214230A1 (en) | Flexible conveyance system | |
EP3323505A4 (en) | Hydrosilylation reaction catalyst | |
GB2556258B (en) | High-performance, low-stress support structure with membrane | |
GB201406997D0 (en) | Flexible cladding, wrap, system and methods | |
HK1211837A1 (en) | Lentiviral vectors containing an mhc class i promoter mhc i | |
EP3023265A4 (en) | Reinforcing member for tire, and tire using same | |
EP3362174A4 (en) | Catalyst carrier | |
IL241898B (en) | Non-phthalate propellants | |
HK1258347A1 (en) | Turbo coding with support for low coding rates | |
EP3364008A4 (en) | Turbo regeneration system | |
GB2512346B (en) | Non-phthalate propellants | |
EP3084566A4 (en) | Typing apparatuses, systems, and methods | |
SG11201605589PA (en) | Device with positioning function, positioning result receiving device, and positioning result utilizing system | |
EP2959150A4 (en) | Rocket delay apparatuses, systems and methods | |
ES1136190Y (en) | Backpack with built-in safety harness | |
FR3001837B1 (en) | CABLE SUPPORT PART, IN PARTICULAR FOR AIRCRAFT. |